Total Payments
$5,051
2024 Payments
$504.06
Companies
25
Transactions
156
Medicare Patients
7,132
Medicare Billing
$1.4M
Payment Breakdown by Category
Food & Beverage$5,031 (99.6%)
Education$20.13 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,031 | 155 | 99.6% |
| Education | $20.13 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,024 | 28 | $0 (2023) |
| ABBVIE INC. | $836.52 | 46 | $0 (2024) |
| Amgen Inc. | $685.07 | 21 | $0 (2024) |
| Nestle HealthCare Nutrition Inc. | $447.37 | 16 | $0 (2022) |
| Boston Scientific Corporation | $299.60 | 4 | $0 (2024) |
| Medtronic, Inc. | $274.75 | 2 | $0 (2023) |
| Abbott Laboratories | $250.39 | 2 | $0 (2022) |
| Relypsa, Inc. | $215.09 | 2 | $0 (2020) |
| Lilly USA, LLC | $212.71 | 11 | $0 (2022) |
| Novo Nordisk Inc | $158.81 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $504.06 | 9 | Boston Scientific Corporation ($275.22) |
| 2023 | $747.36 | 23 | Medtronic, Inc. ($274.75) |
| 2022 | $685.34 | 24 | ABBVIE INC. ($271.88) |
| 2021 | $1,740 | 62 | Nestle HealthCare Nutrition Inc. ($425.91) |
| 2020 | $789.75 | 27 | Amgen Inc. ($242.68) |
| 2019 | $482.70 | 9 | Janssen Pharmaceuticals, Inc ($407.83) |
| 2017 | $102.63 | 2 | Relypsa, Inc. ($90.09) |
All Payment Transactions
156 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | Boston Scientific Corporation | EMBLEM MRI S-ICD (Device) | Food and Beverage | In-kind items and services | $103.10 | General |
| Category: EMBLEM_CRM | ||||||
| 10/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $27.78 | General |
| Category: Cardiology | ||||||
| 06/06/2024 | MIMEDX Group, Inc. | — | Food and Beverage | In-kind items and services | $23.77 | General |
| 05/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $27.20 | General |
| Category: Inflammation | ||||||
| 03/28/2024 | Boston Scientific Corporation | EMBLEM MRI S-ICD (Device) | Food and Beverage | In-kind items and services | $117.50 | General |
| Category: EMBLEM_CRM | ||||||
| 03/13/2024 | Boston Scientific Corporation | EMBLEM MRI S-ICD (Device) | Food and Beverage | In-kind items and services | $54.62 | General |
| Category: EMBLEM_CRM | ||||||
| 01/15/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: NEUROSCIENCE | ||||||
| 01/09/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $122.19 | General |
| 12/14/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/20/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $5.04 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $10.33 | General |
| Category: NEUROSCIENCE | ||||||
| 08/31/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: NEUROSCIENCE | ||||||
| 07/20/2023 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: GI | ||||||
| 06/08/2023 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $152.94 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 06/07/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/23/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/18/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/16/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.29 | General |
| Category: NEUROSCIENCE | ||||||
| 05/15/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.29 | General |
| Category: NEUROSCIENCE | ||||||
| 05/04/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/03/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.63 | General |
| 03/29/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: NEUROSCIENCE | ||||||
| 03/23/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,947 | 5,077 | $860,586 | $350,750 |
| 2022 | 7 | 1,574 | 4,930 | $866,913 | $326,244 |
| 2021 | 10 | 1,619 | 5,160 | $875,945 | $344,242 |
| 2020 | 14 | 1,992 | 5,033 | $936,660 | $340,491 |
Total Patients
7,132
Total Services
20,200
Medicare Billing
$1.4M
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 426 | 3,113 | $508,441 | $224,725 | 44.2% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 416 | 542 | $135,657 | $37,127 | 27.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 279 | 386 | $63,531 | $28,541 | 44.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 146 | 156 | $49,361 | $18,656 | 37.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 95 | 100 | $46,184 | $15,508 | 33.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 98 | 143 | $33,459 | $15,466 | 46.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 398 | 518 | $10,022 | $3,779 | 37.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 67 | 78 | $7,012 | $3,596 | 51.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 41 | $6,919 | $3,353 | 48.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 386 | 3,336 | $542,300 | $220,614 | 40.7% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2022 | 354 | 458 | $115,180 | $32,961 | 28.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 153 | 162 | $74,818 | $29,861 | 39.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 288 | 384 | $63,084 | $25,724 | 40.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 32 | 105 | $52,839 | $9,993 | 18.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 45 | $10,088 | $3,749 | 37.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 342 | 440 | $8,605 | $3,342 | 38.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 387 | 3,468 | $563,758 | $234,246 | 41.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 158 | 181 | $83,593 | $34,109 | 40.8% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Facility | 2021 | 324 | 431 | $111,250 | $31,618 | 28.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 301 | 395 | $64,891 | $26,884 | 41.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 46 | 56 | $16,235 | $5,235 | 32.2% |
| 98926 | Osteopathic manipulative treatment to 3-4 body regions | Facility | 2021 | 34 | 120 | $12,386 | $3,963 | 32.0% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 325 | 429 | $8,271 | $3,333 | 40.3% |
| 93922 | Ultrasound study of arteries of both arms and legs, limited | Office | 2021 | 15 | 27 | $8,350 | $2,267 | 27.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 14 | 26 | $5,219 | $2,205 | 42.2% |
About Dr. Daniel Refoua, DO
Dr. Daniel Refoua, DO is a Internal Medicine healthcare provider based in Great Neck, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2015. The National Provider Identifier (NPI) number assigned to this provider is 1598146383.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Refoua, DO has received a total of $5,051 in payments from pharmaceutical and medical device companies, with $504.06 received in 2024. These payments were reported across 156 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($5,031).
As a Medicare-enrolled provider, Refoua has provided services to 7,132 Medicare beneficiaries, totaling 20,200 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Great Neck, NY
- Active Since 06/17/2015
- Last Updated 08/21/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1598146383
Products in Payments
- XARELTO (Drug) $1,024
- ZENPEP (Drug) $425.91
- EMBLEM MRI S-ICD (Device) $275.22
- Otezla (Drug) $240.55
- LINZESS (Drug) $224.05
- Veltassa (Drug) $215.09
- TRULICITY (Drug) $195.10
- UBRELVY (Drug) $186.35
- LINQ II (Device) $152.94
- Repatha (Biological) $152.78
- CONFIRM RX (Device) $144.93
- VRAYLAR (Drug) $143.47
- Ozempic (Drug) $143.18
- EVENITY (Biological) $141.08
- Xhance (Drug) $125.00
- Aimovig (Biological) $124.93
- COBALT DR MRI SURESCAN (Device) $121.81
- Confirm Rx (Device) $105.46
- QULIPTA (Drug) $104.56
- CREON (Drug) $99.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Great Neck
Dr. Jamie Hirsch, Md, MD
Internal Medicine — Payments: $69,165
Internal Medicine $69,165
Joanne Lee, M.d, M.D
Internal Medicine — Payments: $36,469
Internal Medicine $36,469
Bernard Rosof
Internal Medicine — Payments: $26,679
Internal Medicine $26,679
Dr. Shahram Shamekh, Md, MD
Internal Medicine — Payments: $18,187
Internal Medicine $18,187
Sanford Ratner, M.d, M.D
Internal Medicine — Payments: $16,933
Internal Medicine $16,933
David Edelson, Md, MD
Internal Medicine — Payments: $15,163
Internal Medicine $15,163